|
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series.
|
J Cachexia Sarcopenia Muscle
38343065
|
0 |
8.9 |
2024 |
|
Quantifying the severity of sarcopenia in patients with cancer of the head and neck.
|
Clin Nutr
38484528
|
0 |
6.3 |
2024 |
|
Fluid retention and weight loss in refractory cancer cachexia.
|
BMJ Support Palliat Care
38395597
|
0 |
2.7 |
2024 |
|
Associations of nutrition impact symptoms with dietary intake and eating-related distress in patients with advanced cancer.
|
Clin Nutr ESPEN
38479929
|
0 |
0 |
2024 |
|
Impacts of fluid retention on prognostic abilities of cachexia diagnostic criteria in cancer patients with refractory cachexia.
|
Clin Nutr ESPEN
38479937
|
0 |
0 |
2024 |
|
Cancer Cachexia: ASCO Guideline Rapid Recommendation Update.
|
J Clin Oncol
37467399
|
1 |
45.3 |
2023 |
|
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series.
|
J Cachexia Sarcopenia Muscle
37671529
|
3 |
8.9 |
2023 |
|
The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey.
|
J Cachexia Sarcopenia Muscle
38018293
|
2 |
8.9 |
2023 |
|
Muscle and Adipose Wasting despite Disease Control: Unaddressed Side Effects of Palliative Chemotherapy for Pancreatic Cancer.
|
Cancers (Basel)
37686641
|
0 |
5.2 |
2023 |
|
Prediction of whole body composition utilizing cross-sectional abdominal imaging in pediatrics.
|
Eur J Clin Nutr
36801962
|
0 |
4.7 |
2023 |
|
Factors Associated With Practice of Multimodal Care for Cancer Cachexia Among Physicians and Nurses Engaging in Cancer Care.
|
JCO Oncol Pract
37186884
|
1 |
4 |
2023 |
|
Changes in Sarcopenia Status Predict Survival Among Patients with Resectable Esophageal Cancer.
|
Ann Surg Oncol
37466867
|
2 |
3.7 |
2023 |
|
Explanatory sequential mixed-methods approach to understand how registered dietitians implemented computed tomography skeletal muscle assessments in clinical practice.
|
Nutr Clin Pract
38047580
|
0 |
3.1 |
2023 |
|
Adverse effects of systemic cancer therapy on skeletal muscle: myotoxicity comes out of the closet.
|
Curr Opin Clin Nutr Metab Care
36942895
|
2 |
3.1 |
2023 |
|
Sarcopenia in Lung Cancer: A Narrative Review.
|
Nutr Cancer
37177914
|
1 |
2.9 |
2023 |
|
Low serum creatinine as a prognostic marker in advanced cancer.
|
BMJ Support Palliat Care
37907252
|
0 |
2.7 |
2023 |
|
Association between Consultation by a Comprehensive Integrated Palliative Care Program and Quality of End-of-Life Care in Patients with Advanced Cancer in Edmonton, Canada.
|
Curr Oncol
36661717
|
0 |
2.6 |
2023 |
|
Holistic multimodal care for patients with cancer cachexia and their family caregivers.
|
Asia Pac J Oncol Nurs
38197043
|
1 |
1.8 |
2023 |
|
Current Therapeutic Targets in Cancer Cachexia: A Pathophysiologic Approach.
|
Am Soc Clin Oncol Educ Book
37290034
|
6 |
0 |
2023 |
|
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
|
Can J Surg
38173057
|
0 |
0 |
2023 |
|
Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.
|
Ann Surg
35794004
|
11 |
9 |
2022 |
|
Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta-analysis.
|
J Cachexia Sarcopenia Muscle
36151845
|
2 |
8.9 |
2022 |
|
Development and validation of questionnaires for eating-related distress among advanced cancer patients and families.
|
J Cachexia Sarcopenia Muscle
36403291
|
2 |
8.9 |
2022 |
|
Identification and management of cancer cachexia in patients: Assessment of healthcare providers' knowledge and practice gaps.
|
J Cachexia Sarcopenia Muscle
36218155
|
6 |
8.9 |
2022 |
|
Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle.
|
Eur J Cancer
36403367
|
5 |
8.4 |
2022 |
|
Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis.
|
JHEP Rep
35600667
|
4 |
8.3 |
2022 |
|
Assessing dynamic change in muscle during treatment of patients with cancer: Precision testing standards.
|
Clin Nutr
35395556
|
2 |
6.3 |
2022 |
|
Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis.
|
Cells
35456024
|
5 |
6 |
2022 |
|
Myosteatosis in Cirrhosis: A Review of Diagnosis, Pathophysiological Mechanisms and Potential Interventions.
|
Cells
35406780
|
9 |
6 |
2022 |
|
A Multi-Site, International Audit of Malnutrition Risk and Energy and Protein Intakes in Patients Undergoing Treatment for Head Neck and Esophageal Cancer: Results from INFORM.
|
Nutrients
36558428
|
0 |
5.9 |
2022 |
|
Rapid Standardized CT-Based Method to Determine Lean Body Mass SUV for PET-A Significant Improvement Over Prediction Equations.
|
Front Oncol
35875083
|
0 |
4.7 |
2022 |
|
Body composition and Crohn's disease behavior: Is adiposity the main game changer?
|
Nutrition
36709640
|
0 |
4.4 |
2022 |
|
Impact of Early Jejunostomy Tube Feeding on Clinical Outcome and Parameters of Body Composition in Esophageal Cancer Patients Receiving Multimodal Therapy.
|
Ann Surg Oncol
35616747
|
0 |
3.7 |
2022 |
|
Retrospective study of factors associated with late detection of oral cancer in alberta: A qualitative study.
|
PLoS One
35472099
|
0 |
3.7 |
2022 |
|
Piloting a training program in computed tomography skeletal muscle assessment for registered dietitians.
|
JPEN J Parenter Enteral Nutr
35147237
|
2 |
3.4 |
2022 |
|
Perspectives of Health Care Professionals on Multimodal Interventions for Cancer Cachexia.
|
Palliat Med Rep
36636614
|
5 |
0.01 |
2022 |
|
Factors Associated with Oral Cancerous and Precancerous Lesions in an Underserved Community: A Cross-Sectional Study.
|
Int J Environ Res Public Health
35162318
|
0 |
0.01 |
2022 |
|
Important news on nutritional support in cancer patients - but some EFFORT is still ahead: Referring to Bargetzi et al., 'Nutritional support during hospital stay reduces mortality in patients with different types of cancer: a secondary analysis of a prospective randomized trial'.
|
Ann Oncol
34272040
|
0 |
51.769 |
2021 |
|
Diagnostic criteria for cancer cachexia: reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis.
|
J Cachexia Sarcopenia Muscle
34448539
|
18 |
12.063 |
2021 |
|
Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases.
|
J Cachexia Sarcopenia Muscle
34061469
|
6 |
12.063 |
2021 |
|
Dietary citrulline does not modify rat colon tumor response to chemotherapy, but failed to improve nutritional status.
|
Clin Nutr
34229260
|
2 |
7.643 |
2021 |
|
ESPEN practical guideline: Clinical Nutrition in cancer.
|
Clin Nutr
33946039
|
145 |
7.643 |
2021 |
|
Prognostic value of early changes in CT-measured body composition in patients receiving chemotherapy for unresectable pancreatic cancer.
|
Eur Radiol
33934171
|
11 |
7.034 |
2021 |
|
Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors.
|
Front Oncol
34249760
|
2 |
5.738 |
2021 |
|
Depletion of essential fatty acids in muscle is associated with shorter survival of cancer patients undergoing surgery-preliminary report.
|
Sci Rep
34836998
|
1 |
4.996 |
2021 |
|
Adequacy of nutritional support using computed tomography (CT) in patients with head and neck cancer (HNC) during chemo-radiotherapy (CRT).
|
Eur J Clin Nutr
33568807
|
1 |
4.884 |
2021 |
|
Psychological symptoms of illness and emotional distress in advanced cancer cachexia.
|
Curr Opin Clin Nutr Metab Care
34966115
|
9 |
3.1 |
2021 |
|
Oral Cavity and Oropharyngeal Cancer Surveillance and Control in Alberta: A Scoping Review.
|
J Can Dent Assoc
34343067
|
2 |
1.348 |
2021 |
|
CT-based assessment of body composition and skeletal muscle in melanoma: A systematic review.
|
Clin Nutr ESPEN
34620308
|
2 |
0 |
2021 |
|
Management of Cancer Cachexia: ASCO Guideline.
|
J Clin Oncol
32432946
|
123 |
44.544 |
2020 |
|
Association of Low Muscle Mass and Low Muscle Radiodensity With Morbidity and Mortality for Colon Cancer Surgery.
|
JAMA Surg
32805015
|
41 |
14.766 |
2020 |
|
Sarcopenia and low muscle radiodensity associate with impaired FEV in allogeneic haematopoietic stem cell transplant recipients.
|
J Cachexia Sarcopenia Muscle
32729255
|
11 |
12.91 |
2020 |
|
Lipid is heterogeneously distributed in muscle and associates with low radiodensity in cancer patients.
|
J Cachexia Sarcopenia Muscle
31989803
|
14 |
12.91 |
2020 |
|
Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients.
|
J Cachexia Sarcopenia Muscle
32314543
|
22 |
12.91 |
2020 |
|
Review article: prognostic significance of body composition abnormalities in patients with cirrhosis.
|
Aliment Pharmacol Ther
32621329
|
13 |
8.171 |
2020 |
|
Concurrent losses of skeletal muscle mass, adipose tissue and bone mineral density during bevacizumab / cytotoxic chemotherapy treatment for metastatic colorectal cancer.
|
Clin Nutr
32164981
|
4 |
7.324 |
2020 |
|
Visceral Adipose Tissue Radiodensity Is Linked to Prognosis in Hepatocellular Carcinoma Patients Treated with Selective Internal Radiation Therapy.
|
Cancers (Basel)
32033166
|
8 |
6.639 |
2020 |
|
Computed-Tomography Body Composition Analysis Complements Pre-Operative Nutrition Screening in Colorectal Cancer Patients on an Enhanced Recovery after Surgery Pathway.
|
Nutrients
33291416
|
7 |
5.717 |
2020 |
|
Sarcopenia Severity Based on Computed Tomography Image Analysis in Patients with Cirrhosis.
|
Nutrients
33187310
|
8 |
5.717 |
2020 |
|
Deep learning method for localization and segmentation of abdominal CT.
|
Comput Med Imaging Graph
32862015
|
7 |
4.79 |
2020 |
|
FIT: Functional and imaging testing for patients with metastatic cancer.
|
Support Care Cancer
32990784
|
1 |
3.359 |
2020 |
|
Dentition, nutritional status and adequacy of dietary intake in treatment naïve head and neck cancer patients.
|
Heliyon
32258472
|
3 |
2.812 |
2020 |
|
Response Regarding: Thigh Ultrasound Used to Identify Frail Elderly Patients With Sarcopenia Undergoing Surgery: A Pilot Study.
|
J Surg Res
33308827
|
0 |
2.417 |
2020 |
|
Thigh Ultrasound Used to Identify Frail Elderly Patients with Sarcopenia Undergoing Surgery: A Pilot Study.
|
J Surg Res
32795705
|
3 |
2.192 |
2020 |
|
Frequency, Timing, and Predictors of Palliative Care Consultation in Patients with Advanced Cancer at a Tertiary Cancer Center: Secondary Analysis of Routinely Collected Health Data.
|
Oncologist
32445194
|
1 |
2.176 |
2020 |
|
Body Composition Influences Post-Operative Complications and 90-Day and Overall Survival in Pancreatic Surgery Patients.
|
GE Port J Gastroenterol
33564701
|
4 |
0 |
2020 |
|
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
|
Ann Oncol
32169202
|
30 |
14.196 |
2019 |
|
Clinical and biological characterization of skeletal muscle tissue biopsies of surgical cancer patients.
|
J Cachexia Sarcopenia Muscle
31307124
|
17 |
9.802 |
2019 |
|
Sarcopenia: A Time for Action. An SCWD Position Paper.
|
J Cachexia Sarcopenia Muscle
31523937
|
174 |
9.802 |
2019 |
|
Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
|
J Cachexia Sarcopenia Muscle
31293070
|
14 |
9.802 |
2019 |
|
Low muscle mass is associated with early termination of chemotherapy related to toxicity in patients with head and neck cancer.
|
Clin Nutr
30846324
|
22 |
7.324 |
2019 |
|
Prevalence and prognostic significance of malnutrition in patients with cancers of the head and neck.
|
Clin Nutr
31000341
|
23 |
7.324 |
2019 |
|
Determinants of change in resting energy expenditure in patients with stage III/IV colorectal cancer.
|
Clin Nutr
30975554
|
7 |
7.324 |
2019 |
|
The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer.
|
Am J Clin Nutr
30850836
|
14 |
6.766 |
2019 |
|
Integration of palliative, supportive, and nutritional care to alleviate eating-related distress among advanced cancer patients with cachexia and their family members.
|
Crit Rev Oncol Hematol
31563078
|
19 |
5.833 |
2019 |
|
Cancer-Associated Malnutrition and CT-Defined Sarcopenia and Myosteatosis Are Endemic in Overweight and Obese Patients.
|
JPEN J Parenter Enteral Nutr
31012128
|
34 |
4.016 |
2019 |
|
The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
|
Dis Colon Rectum
30789442
|
46 |
3.991 |
2019 |
|
Dietary patterns and their relationships to sarcopenia in Portuguese patients with gastrointestinal cancer: An exploratory study.
|
Nutrition
31029047
|
3 |
3.769 |
2019 |
|
Immunohistochemical phenotyping of T cells, granulocytes, and phagocytes in the muscle of cancer patients: association with radiologically defined muscle mass and gene expression.
|
Skelet Muscle
31521204
|
7 |
3.754 |
2019 |
|
Muscle segmentation in axial computed tomography (CT) images at the lumbar (L3) and thoracic (T4) levels for body composition analysis.
|
Comput Med Imaging Graph
31132616
|
18 |
3.75 |
2019 |
|
Profiling Determinants of Resting Energy Expenditure in Colorectal Cancer.
|
Nutr Cancer
31282744
|
4 |
2.9 |
2019 |
|
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
|
Radiat Oncol
31511012
|
17 |
2.817 |
2019 |
|
Convergent neuronal projections from paraventricular nucleus, parabrachial nucleus, and brainstem onto gastrocnemius muscle, white and brown adipose tissue in male rats.
|
J Comp Neurol
31045239
|
5 |
2.801 |
2019 |
|
Accuracy of Resting Energy Expenditure Predictive Equations in Patients With Cancer.
|
Nutr Clin Pract
31347209
|
6 |
2.573 |
2019 |
|
Canadian Nutrition Society: Scientific Abstracts from the 10th Annual Scientific Meeting / Société canadienne de nutrition: Résumés scientifiques de la 10 réunion scientifique annuelle.
|
Appl Physiol Nutr Metab
30983410
|
1 |
2.522 |
2019 |
|
Change in Skeletal Muscle Following Resection of Stage I-III Colorectal Cancer is Predictive of Poor Survival: A Cohort Study.
|
World J Surg
31222643
|
12 |
2.234 |
2019 |
|
A prospective study examining cachexia predictors in patients with incurable cancer.
|
BMC Palliat Care
31164115
|
9 |
2.015 |
2019 |
|
Cancer cachexia is defined by an ongoing loss of skeletal muscle mass.
|
Ann Palliat Med
30685982
|
37 |
1.681 |
2019 |
|
Proceedings of the Canadian Frailty Network Workshop: Identifying Biomarkers of Frailty to Support Frailty Risk Assessment, Diagnosis and Prognosis. Toronto, January 15, 2018.
|
J Frailty Aging
31237310
|
3 |
0 |
2019 |
|
Bridging the gap: are animal models consistent with clinical cancer cachexia?
|
Nat Rev Clin Oncol
29405197
|
8 |
34.106 |
2018 |
|
Cancer-associated cachexia.
|
Nat Rev Dis Primers
29345251
|
460 |
32.274 |
2018 |
|
Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
|
J Hepatol
29709682
|
36 |
18.946 |
2018 |
|
Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
|
Hepatology
29023899
|
22 |
14.971 |
2018 |
|
Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials.
|
Ann Oncol
29788170
|
66 |
14.196 |
2018 |
|
Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy.
|
Ann Oncol
29506228
|
73 |
14.196 |
2018 |
|
Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer.
|
J Cachexia Sarcopenia Muscle
29675984
|
28 |
10.754 |
2018 |
|
Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases.
|
J Cachexia Sarcopenia Muscle
30378742
|
9 |
9.802 |
2018 |
|
Assessing dietary intake in accordance with guidelines: Useful correlations with an ingesta-Verbal/Visual Analogue Scale in medical oncology patients.
|
Clin Nutr
30355527
|
5 |
6.36 |
2018 |
|
Barriers to cancer nutrition therapy: excess catabolism of muscle and adipose tissues induced by tumour products and chemotherapy.
|
Proc Nutr Soc
29708079
|
24 |
5.017 |
2018 |
|
Cancer cachexia: Diagnosis, assessment, and treatment.
|
Crit Rev Oncol Hematol
29891116
|
66 |
5.012 |
2018 |
|
Barriers to the Interpretation of Body Composition in Colorectal Cancer: A Review of the Methodological Inconsistency and Complexity of the CT-Defined Body Habitus.
|
Ann Surg Oncol
29488190
|
8 |
3.681 |
2018 |
|
Assessment of Computed Tomography (CT)-Defined Muscle and Adipose Tissue Features in Relation to Short-Term Outcomes After Elective Surgery for Colorectal Cancer: A Multicenter Approach.
|
Ann Surg Oncol
30006691
|
30 |
3.681 |
2018 |
|
Single-Nucleotide Polymorphisms in TAOK3 Are Associated With High Opioid Requirement for Pain Management in Patients With Advanced Cancer Admitted to a Tertiary Palliative Care Unit.
|
J Pain Symptom Manage
30031856
|
4 |
3.378 |
2018 |
|
A comparison of CT based measures of skeletal muscle mass and density from the Th4 and L3 levels in patients with advanced non-small-cell lung cancer.
|
Eur J Clin Nutr
30254241
|
8 |
3.291 |
2018 |
|
Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial.
|
BMJ Support Palliat Care
29440149
|
69 |
3.208 |
2018 |
|
Cancer-associated malnutrition.
|
Eur J Clin Nutr
30185853
|
45 |
3.114 |
2018 |
|
Sarcopenia and myosteatosis are accompanied by distinct biological profiles in patients with pancreatic and periampullary adenocarcinomas.
|
PLoS One
29723245
|
42 |
2.9 |
2018 |
|
Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.
|
Support Care Cancer
30547303
|
4 |
2.635 |
2018 |
|
Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis.
|
Dis Esophagus
29846548
|
46 |
2.323 |
2018 |
|
Head and Neck Cancer Patients Do Not Meet Recommended Intakes of Micronutrients without Consuming Fortified Products.
|
Nutr Cancer
29533097
|
4 |
2.029 |
2018 |
|
The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis.
|
J Cachexia Sarcopenia Muscle
28627024
|
30 |
12.511 |
2017 |
|
Psoas as a sentinel muscle for sarcopenia: a flawed premise.
|
J Cachexia Sarcopenia Muscle
28675689
|
59 |
12.511 |
2017 |
|
Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia.
|
J Cachexia Sarcopenia Muscle
28058815
|
40 |
12.511 |
2017 |
|
Muscle mass and association to quality of life in non-small cell lung cancer patients.
|
J Cachexia Sarcopenia Muscle
28493418
|
43 |
12.511 |
2017 |
|
Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia.
|
J Cachexia Sarcopenia Muscle
28984045
|
18 |
10.754 |
2017 |
|
High fat mass associates with occurrence of targeted therapy-induced left ventricular ejection fraction reduction in patients with renal cell carcinoma.
|
Clin Nutr
28392165
|
0 |
6.402 |
2017 |
|
Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
|
Br J Cancer
28588319
|
69 |
5.922 |
2017 |
|
ESPEN expert group recommendations for action against cancer-related malnutrition.
|
Clin Nutr
28689670
|
248 |
5.496 |
2017 |
|
Mitogen-Activated Protein Kinases Inhibitors: Potential Therapeutic Agents for Cancer Cachexia.
|
Mol Cancer Ther
28159914
|
1 |
5.365 |
2017 |
|
Management of Cancer Cachexia and Guidelines Implementation in a Comprehensive Cancer Center: A Physician-Led Cancer Nutrition Program Adapted to the Practices of a Country.
|
J Pain Symptom Manage
28778558
|
4 |
3.249 |
2017 |
|
Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer.
|
PLoS One
28832677
|
11 |
2.992 |
2017 |
|
Professor Kenneth Fearon: 3 August 1960-3 September 2016.
|
Eur J Clin Nutr
28050025
|
0 |
2.954 |
2017 |
|
International Association for Hospice and Palliative Care Endorses Volitional Death by Starvation and Dehydration.
|
J Palliat Med
28437211
|
0 |
2.49 |
2017 |
|
Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer.
|
J Gastric Cancer
28337365
|
44 |
1.4 |
2017 |
|
Lower skeletal muscle attenuation and high visceral fat index are associated with complicated disease in patients with Crohn's disease: An exploratory study.
|
Clin Nutr ESPEN
30014873
|
20 |
0.613 |
2017 |
|
Poor Physical Function as a Marker of Sarcopenia in Adults with Class II/III Obesity.
|
Curr Dev Nutr
30377678
|
3 |
0 |
2017 |
|
Ken Fearon.
|
Cell Metab
28034417
|
0 |
18.164 |
2016 |
|
Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy.
|
J Cachexia Sarcopenia Muscle
27897411
|
33 |
12.511 |
2016 |
|
New genetic signatures associated with cancer cachexia as defined by low skeletal muscle index and weight loss.
|
J Cachexia Sarcopenia Muscle
27897403
|
33 |
12.511 |
2016 |
|
Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.
|
Oncogene
27212031
|
27 |
7.519 |
2016 |
|
ESPEN guidelines on nutrition in cancer patients.
|
Clin Nutr
27637832
|
604 |
5.496 |
2016 |
|
The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer.
|
Oncotarget
26934122
|
14 |
5.168 |
2016 |
|
In Reply.
|
Oncologist
26768484
|
0 |
4.962 |
2016 |
|
Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
|
Clin Nutr
27102408
|
48 |
4.548 |
2016 |
|
Loss of visceral adipose tissue precedes subcutaneous adipose tissue and associates with n-6 fatty acid content.
|
Clin Nutr
26972089
|
12 |
4.548 |
2016 |
|
Drug Dose Per Kilogram Lean Body Mass Predicts Hematologic Toxicity From Carboplatin-Doublet Chemotherapy in Advanced Non-Small-Cell Lung Cancer.
|
Clin Lung Cancer
27825639
|
17 |
4.204 |
2016 |
|
Recommended European Society of Parenteral and Enteral Nutrition protein and energy intakes and weight loss in patients with head and neck cancer.
|
Head Neck
27028732
|
9 |
3.376 |
2016 |
|
Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens.
|
Cancer Med
26814378
|
50 |
3.362 |
2016 |
|
Key determinants of energy expenditure in cancer and implications for clinical practice.
|
Eur J Clin Nutr
27273068
|
36 |
3.057 |
2016 |
|
Can body composition be used to optimize the dose of platinum chemotherapy in lung cancer? A feasibility study.
|
Support Care Cancer
27933464
|
5 |
2.676 |
2016 |
|
Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials.
|
Support Care Cancer
27628947
|
18 |
2.676 |
2016 |
|
Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a debilitating intersection of sarcopenia, cachexia and breathlessness.
|
Curr Opin Support Palliat Care
27380222
|
11 |
2.045 |
2016 |
|
Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer.
|
BMJ Support Palliat Care
27342412
|
26 |
0 |
2016 |
|
Body Composition in Relation to Clinical Outcomes in Renal Cell Cancer: A Systematic Review and Meta-analysis.
|
Eur Urol Focus
28753824
|
20 |
0 |
2016 |
|
Cancer Cachexia: Beyond Weight Loss.
|
J Oncol Pract
27858548
|
73 |
0 |
2016 |
|
Let Them Eat Fish.
|
JAMA Oncol
26355864
|
1 |
16.559 |
2015 |
|
Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver.
|
J Cachexia Sarcopenia Muscle
27066321
|
11 |
9.697 |
2015 |
|
Request for regulatory guidance for cancer cachexia intervention trials.
|
J Cachexia Sarcopenia Muscle
26675232
|
57 |
9.697 |
2015 |
|
Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
|
J Cachexia Sarcopenia Muscle
27493866
|
166 |
9.697 |
2015 |
|
Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomes.
|
Semin Cell Dev Biol
26343952
|
91 |
6.614 |
2015 |
|
Inactivation of the ubiquitin-specific protease 19 deubiquitinating enzyme protects against muscle wasting.
|
FASEB J
26048142
|
22 |
5.498 |
2015 |
|
Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer.
|
Oncologist
26173839
|
34 |
4.789 |
2015 |
|
Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer.
|
Lung Cancer
26198373
|
26 |
4.294 |
2015 |
|
Muscle wasting: is mitochondrial dysfunction a key target?
|
Curr Opin Clin Nutr Metab Care
25807356
|
3 |
4.023 |
2015 |
|
Body Composition Assessment in Axial CT Images Using FEM-Based Automatic Segmentation of Skeletal Muscle.
|
IEEE Trans Med Imaging
26415164
|
45 |
3.942 |
2015 |
|
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.
|
Clin Transl Gastroenterol
26181291
|
97 |
3.923 |
2015 |
|
Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy.
|
PLoS One
26030144
|
20 |
3.502 |
2015 |
|
Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus.
|
PLoS One
26444289
|
4 |
3.502 |
2015 |
|
Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review.
|
World J Gastroenterol
25632180
|
17 |
3.365 |
2015 |
|
Development of a new equation to estimate creatinine clearance in cancer patients.
|
Cancer Chemother Pharmacol
25986679
|
1 |
2.737 |
2015 |
|
Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia.
|
Theor Biol Med Model
26370269
|
34 |
1.46 |
2015 |
|
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.
|
Nature
25043053
|
287 |
40.137 |
2014 |
|
Skeletal muscle anabolism in patients with advanced cancer.
|
Lancet Oncol
25524803
|
11 |
33.9 |
2014 |
|
Diagnostic criteria for the classification of cancer-associated weight loss.
|
J Clin Oncol
25422490
|
200 |
24.008 |
2014 |
|
Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model--a study based on data from an international multicentre project (EPCRC-CSA).
|
Ann Oncol
24562443
|
79 |
11.855 |
2014 |
|
Nutritional assessment in overweight and obese patients with metastatic cancer: does it make sense?
|
Ann Oncol
25361991
|
13 |
11.855 |
2014 |
|
An invitation to the 2nd Cancer Cachexia Conference, Montréal, Canada.
|
J Cachexia Sarcopenia Muscle
24965540
|
0 |
9.697 |
2014 |
|
Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist.
|
J Cachexia Sarcopenia Muscle
24627226
|
36 |
9.697 |
2014 |
|
Measurement of skeletal muscle radiation attenuation and basis of its biological variation.
|
Acta Physiol (Oxf)
24393306
|
220 |
4.867 |
2014 |
|
Nutrition impact symptoms in a population cohort of head and neck cancer patients: multivariate regression analysis of symptoms on oral intake, weight loss and survival.
|
Oral Oncol
25017804
|
31 |
4.794 |
2014 |
|
Identifying the Barriers and Enablers to Nutrition Care in Head and Neck and Esophageal Cancers: An International Qualitative Study.
|
JPEN J Parenter Enteral Nutr
25288589
|
17 |
4.22 |
2014 |
|
Too little or too much are inadequate.
|
Curr Opin Clin Nutr Metab Care
24625839
|
0 |
4.023 |
2014 |
|
Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
|
Liver Transpl
24678005
|
96 |
3.91 |
2014 |
|
Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery.
|
Surgery
24929435
|
51 |
3.904 |
2014 |
|
The role of intestinal microbiota in development of irinotecan toxicity and in toxicity reduction through dietary fibres in rats.
|
PLoS One
24454707
|
29 |
3.706 |
2014 |
|
Depression in advanced cancer--assessment challenges and associations with disease load.
|
J Affect Disord
25462414
|
14 |
3.432 |
2014 |
|
Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
|
J Clin Gastroenterol
23751844
|
99 |
3.186 |
2014 |
|
Correlates of objectively measured sedentary behavior in cancer patients with brain metastases: an application of the theory of planned behavior.
|
Psychooncology
25073628
|
2 |
3.095 |
2014 |
|
Associations between objectively measured physical activity and quality of life in cancer patients with brain metastases.
|
J Pain Symptom Manage
24630754
|
15 |
2.905 |
2014 |
|
The association between body composition and toxicities from the combination of Doxil and trabectedin in patients with advanced relapsed ovarian cancer.
|
Appl Physiol Nutr Metab
24869973
|
19 |
2.023 |
2014 |
|
Genetic basis of interindividual susceptibility to cancer cachexia: selection of potential candidate gene polymorphisms for association studies.
|
J Genet
25572253
|
13 |
0.995 |
2014 |
|
Age, Obesity, Sarcopenia, and Proximity to Death Explain Reduced Mean Muscle Attenuation in Patients with Advanced Cancer.
|
J Frailty Aging
27049818
|
9 |
0 |
2014 |
|
Clinical trials of cancer cachexia therapy, now and hereafter.
|
J Clin Oncol
23439747
|
9 |
24.008 |
2013 |
|
Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
|
J Clin Oncol
23530101
|
849 |
24.008 |
2013 |
|
Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
|
Am J Clin Nutr
23966429
|
92 |
6.926 |
2013 |
|
Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.
|
Cancer
23801109
|
85 |
6.072 |
2013 |
|
Body composition and survival in the early clinical trials setting.
|
Eur J Cancer
23867127
|
14 |
6.029 |
2013 |
|
Body composition variation and impact of low skeletal muscle mass in patients with advanced medullary thyroid carcinoma treated with vandetanib: results from a placebo-controlled study.
|
J Clin Endocrinol Metab
23543666
|
34 |
5.455 |
2013 |
|
Malnutrition assessment in patients with cancers of the head and neck: a call to action and consensus.
|
Crit Rev Oncol Hematol
23830808
|
19 |
4.971 |
2013 |
|
Effects of sample size on differential gene expression, rank order and prediction accuracy of a gene signature.
|
PLoS One
23755224
|
25 |
4.034 |
2013 |
|
The nutrition swing.
|
Curr Opin Clin Nutr Metab Care
23481150
|
0 |
4.023 |
2013 |
|
Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses.
|
Int J Biochem Cell Biol
23819995
|
42 |
3.505 |
2013 |
|
Low skeletal muscle is associated with toxicity in patients included in phase I trials.
|
Invest New Drugs
24343673
|
27 |
3.484 |
2013 |
|
Development and testing of a computerized pain body map in patients with advanced cancer.
|
J Pain Symptom Manage
23856098
|
7 |
2.905 |
2013 |
|
The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss.
|
Support Care Cancer
23852426
|
16 |
2.698 |
2013 |
|
Assessment of nutritional status in cancer--the relationship between body composition and pharmacokinetics.
|
Anticancer Agents Med Chem
23919745
|
33 |
2.598 |
2013 |
|
The Edmonton Classification System for Cancer Pain: comparison of pain classification features and pain intensity across diverse palliative care settings in eight countries.
|
J Palliat Med
23614710
|
12 |
2.23 |
2013 |
|
Home-based functional walking program for advanced cancer patients receiving palliative care: a case series.
|
BMC Palliat Care
23663868
|
7 |
1.602 |
2013 |
|
Depressed patients with incurable cancer: which depressive symptoms do they experience?
|
Palliat Support Care
23388067
|
7 |
1.199 |
2013 |
|
Sarcopenia and physical function in overweight patients with advanced cancer.
|
Can J Diet Pract Res
23750978
|
27 |
0.5 |
2013 |
|
Understanding the mechanisms and treatment options in cancer cachexia.
|
Nat Rev Clin Oncol
23207794
|
347 |
20.693 |
2012 |
|
Is there a genetic cause of appetite loss?-an explorative study in 1,853 cancer patients.
|
J Cachexia Sarcopenia Muscle
22535570
|
5 |
9.697 |
2012 |
|
P-selectin genotype is associated with the development of cancer cachexia.
|
EMBO Mol Med
22473907
|
19 |
9.249 |
2012 |
|
Skeletal muscle anabolism is a side effect of therapy with the MEK inhibitor: selumetinib in patients with cholangiocarcinoma.
|
Br J Cancer
22510747
|
45 |
6.176 |
2012 |
|
Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery.
|
Br J Cancer
22871883
|
236 |
6.176 |
2012 |
|
Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results.
|
Clin Nutr
22695408
|
57 |
4.548 |
2012 |
|
Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service.
|
PLoS One
22235285
|
34 |
4.285 |
2012 |
|
Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats.
|
PLoS One
22844397
|
58 |
4.285 |
2012 |
|
Advances in the science and application of body composition measurement.
|
JPEN J Parenter Enteral Nutr
22235108
|
23 |
4.22 |
2012 |
|
Muscle wasting: a crosstalk between protein synthesis and breakdown signalling.
|
Curr Opin Clin Nutr Metab Care
22466927
|
2 |
4.023 |
2012 |
|
Survival: the relevant primary outcome for nutrition therapy in cancer patients.
|
Curr Opin Clin Nutr Metab Care
22466928
|
3 |
4.023 |
2012 |
|
Severe muscle depletion in patients on the liver transplant wait list: its prevalence and independent prognostic value.
|
Liver Transpl
22740290
|
177 |
3.91 |
2012 |
|
Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: a prospective longitudinal view.
|
Head Neck
22730077
|
27 |
3.376 |
2012 |
|
Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2).
|
Bioorg Med Chem
22386983
|
5 |
2.93 |
2012 |
|
Interviews with patients with advanced cancer--another step towards an international cancer pain classification system.
|
Support Care Cancer
22252546
|
2 |
2.698 |
2012 |
|
Evaluation of the clinical relevance of body composition parameters in patients with cancer metastatic to the liver treated with hepatic arterial infusion chemotherapy.
|
Nutr Cancer
22229660
|
7 |
2.447 |
2012 |
|
Reframing eating during chemotherapy in cancer patients with chemosensory alterations.
|
Eur J Oncol Nurs
22265664
|
11 |
1.826 |
2012 |
|
Dietary patterns of patients with advanced lung or colorectal cancer.
|
Can J Diet Pract Res
23217447
|
7 |
0.5 |
2012 |
|
Definition and classification of cancer cachexia: an international consensus.
|
Lancet Oncol
21296615
|
1701 |
33.9 |
2011 |
|
Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies.
|
Annu Rev Med
20731602
|
121 |
13.609 |
2011 |
|
Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.
|
J Exp Med
22084407
|
81 |
11.991 |
2011 |
|
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial.
|
Ann Oncol
21343383
|
65 |
11.855 |
2011 |
|
Pitfalls in defining and quantifying cachexia.
|
J Cachexia Sarcopenia Muscle
21766051
|
11 |
9.697 |
2011 |
|
Muscle wasting is associated with mortality in patients with cirrhosis.
|
Clin Gastroenterol Hepatol
21893129
|
256 |
7.398 |
2011 |
|
Is there a genetic cause for cancer cachexia? - a clinical validation study in 1797 patients.
|
Br J Cancer
21934689
|
5 |
6.176 |
2011 |
|
Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer.
|
Br J Cancer
21448173
|
216 |
6.176 |
2011 |
|
Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.
|
Cancer
21328326
|
49 |
6.072 |
2011 |
|
Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy.
|
Cancer
21360698
|
70 |
6.072 |
2011 |
|
Sarcopenia with limited mobility: an international consensus.
|
J Am Med Dir Assoc
21640657
|
337 |
5.775 |
2011 |
|
Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer.
|
Crit Rev Oncol Hematol
21216616
|
76 |
4.971 |
2011 |
|
Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis.
|
Lung Cancer
21632145
|
26 |
4.294 |
2011 |
|
Nutrition modulation of gastrointestinal toxicity related to cancer chemotherapy: from preclinical findings to clinical strategy.
|
JPEN J Parenter Enteral Nutr
21224434
|
16 |
4.22 |
2011 |
|
Spinal opioids in adult patients with cancer pain: a systematic review: a European Palliative Care Research Collaborative (EPCRC) opioid guidelines project.
|
Palliat Med
21708860
|
8 |
4.22 |
2011 |
|
Prediction of skeletal muscle and fat mass in patients with advanced cancer using a metabolomic approach.
|
J Nutr
22157537
|
15 |
4.145 |
2011 |
|
Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity.
|
Curr Opin Clin Nutr Metab Care
21415735
|
51 |
4.023 |
2011 |
|
Would you buy a new tool to improve your practice?
|
Curr Opin Clin Nutr Metab Care
21460718
|
1 |
4.023 |
2011 |
|
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review.
|
J Pain Symptom Manage
21621130
|
624 |
2.905 |
2011 |
|
Characterization of chemosensory alterations in advanced cancer reveals specific chemosensory phenotypes impacting dietary intake and quality of life.
|
J Pain Symptom Manage
21276701
|
19 |
2.905 |
2011 |
|
Synthesis and evaluation of 1,5-diaryl-substituted tetrazoles as novel selective cyclooxygenase-2 (COX-2) inhibitors.
|
Bioorg Med Chem Lett
21316237
|
11 |
2.454 |
2011 |
|
Baseline insulin-like growth factor-I plasma levels, systemic inflammation, weight loss and clinical outcome in metastatic non-small cell lung cancer patients.
|
Oncology
21986483
|
10 |
2.262 |
2011 |
|
The advantages and limitations of cross-sectional body composition analysis.
|
Curr Opin Support Palliat Care
21986910
|
31 |
2.045 |
2011 |
|
Determinants of physical activity in palliative cancer patients: an application of the theory of planned behavior.
|
J Support Oncol
21996569
|
5 |
0 |
2011 |
|
Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: results from a placebo-controlled study.
|
J Clin Oncol
20085939
|
106 |
24.008 |
2010 |
|
Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction.
|
J Clin Oncol
20805456
|
40 |
24.008 |
2010 |
|
Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma.
|
Ann Oncol
20089558
|
151 |
11.855 |
2010 |
|
Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history.
|
Ann Oncol
20937647
|
23 |
11.855 |
2010 |
|
Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
|
Am J Clin Nutr
20164322
|
148 |
6.926 |
2010 |
|
A comparison of Charlson and Elixhauser comorbidity measures to predict colorectal cancer survival using administrative health data.
|
Cancer
21509773
|
59 |
6.072 |
2010 |
|
Consensus on cachexia definitions.
|
J Am Med Dir Assoc
20439040
|
44 |
5.775 |
2010 |
|
MAFbx/Atrogin-1 expression is a poor index of muscle proteolysis.
|
Curr Opin Clin Nutr Metab Care
20393275
|
24 |
4.023 |
2010 |
|
Nutrition impact symptoms: key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment.
|
Head Neck
19626639
|
58 |
3.376 |
2010 |
|
Cachexia in pancreatic cancer: new treatment options and measures of success.
|
HPB (Oxford)
20590907
|
31 |
3.29 |
2010 |
|
Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.
|
Eur J Pain
20822941
|
21 |
3.019 |
2010 |
|
An exploratory study of body composition as a determinant of epirubicin pharmacokinetics and toxicity.
|
Cancer Chemother Pharmacol
20204364
|
50 |
2.737 |
2010 |
|
Evolving classification systems for cancer cachexia: ready for clinical practice?
|
Support Care Cancer
20076976
|
26 |
2.698 |
2010 |
|
Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment.
|
Clin Cancer Res
19351764
|
366 |
9.619 |
2009 |
|
Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer.
|
Clin Cancer Res
19887488
|
227 |
9.619 |
2009 |
|
A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.
|
Am J Clin Nutr
19244378
|
94 |
6.926 |
2009 |
|
Prophylactic ciprofloxacin treatment prevented high mortality, and modified systemic and intestinal immune function in tumour-bearing rats receiving dose-intensive CPT-11 chemotherapy.
|
Br J Cancer
19401694
|
7 |
6.176 |
2009 |
|
Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients.
|
Clin Nutr
19959263
|
54 |
4.548 |
2009 |
|
Depression assessment and classification in palliative cancer patients: a systematic literature review.
|
Palliat Med
19825894
|
16 |
4.22 |
2009 |
|
Single and combined supplementation of glutamine and n-3 polyunsaturated fatty acids on host tolerance and tumour response to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin (CPT-11)/5-fluorouracil chemotherapy in rats bearing Ward colon tumour.
|
Br J Nutr
19250573
|
11 |
3.706 |
2009 |
|
Associations between physical activity and quality of life in cancer patients receiving palliative care: a pilot survey.
|
J Pain Symptom Manage
19775864
|
18 |
2.905 |
2009 |
|
Physical activity interests and preferences in palliative cancer patients.
|
Support Care Cancer
19902273
|
31 |
2.698 |
2009 |
|
The detection of depression in palliative care.
|
Curr Opin Support Palliat Care
19365162
|
10 |
2.045 |
2009 |
|
The emerging role of computerized tomography in assessing cancer cachexia.
|
Curr Opin Support Palliat Care
19667996
|
83 |
2.045 |
2009 |
|
Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.
|
Lancet Oncol
18539529
|
961 |
33.9 |
2008 |
|
Cachexia: a new definition.
|
Clin Nutr
18718696
|
776 |
4.548 |
2008 |
|
Bolus oral glutamine protects rats against CPT-11-induced diarrhea and differentially activates cytoprotective mechanisms in host intestine but not tumor.
|
J Nutr
18356329
|
14 |
4.145 |
2008 |
|
Computational modeling of cancer cachexia.
|
Curr Opin Clin Nutr Metab Care
18403915
|
19 |
4.023 |
2008 |
|
The dermcidin gene in cancer: role in cachexia, carcinogenesis and tumour cell survival.
|
Curr Opin Clin Nutr Metab Care
18403914
|
10 |
4.023 |
2008 |
|
A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.
|
Appl Physiol Nutr Metab
18923576
|
665 |
2.023 |
2008 |
|
Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity.
|
Clin Cancer Res
17545532
|
185 |
9.619 |
2007 |
|
Nutritional modulation of antitumor efficacy and diarrhea toxicity related to irinotecan chemotherapy in rats bearing the ward colon tumor.
|
Clin Cancer Res
18056195
|
29 |
9.619 |
2007 |
|
Is there a human homologue to the murine proteolysis-inducing factor?
|
Clin Cancer Res
17785548
|
13 |
9.619 |
2007 |
|
Shifting to conscious control: psychosocial and dietary management of anorexia by patients with advanced cancer.
|
Palliat Med
17641076
|
15 |
4.22 |
2007 |
|
Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer.
|
J Pain Symptom Manage
17280921
|
63 |
2.905 |
2007 |
|
More research needed on the treatment of the cancer anorexia/cachexia syndrome.
|
J Support Oncol
17136866
|
0 |
0 |
2007 |
|
Cancer-associated cachexia and underlying biological mechanisms.
|
Annu Rev Nutr
16602932
|
34 |
9.054 |
2006 |
|
Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy.
|
Am J Clin Nutr
17093170
|
30 |
6.926 |
2006 |
|
The management of anorexia by patients with advanced cancer: a critical review of the literature.
|
Palliat Med
17060256
|
4 |
4.22 |
2006 |
|
Investigations of branched-chain amino acids and their metabolites in animal models of cancer.
|
J Nutr
16365090
|
39 |
4.145 |
2006 |
|
Integration of amino acid metabolism during intense lactation.
|
Curr Opin Clin Nutr Metab Care
16444819
|
0 |
4.023 |
2006 |
|
Glutamine supplementation influences immune development in the newly weaned piglet.
|
Dev Comp Immunol
16697041
|
12 |
3.218 |
2006 |
|
Drug utilization review on a tertiary palliative care unit.
|
J Pain Symptom Manage
16716876
|
1 |
2.905 |
2006 |
|
Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer--an argument for the application of sensory science.
|
J Palliat Care
17265664
|
15 |
0.618 |
2006 |
|
Effects of exercise training on antitumor efficacy of doxorubicin in MDA-MB-231 breast cancer xenografts.
|
Clin Cancer Res
16166449
|
28 |
9.619 |
2005 |
|
A proinflammatory tumor that activates protein degradation sensitizes rats to catabolic effects of endotoxin.
|
Am J Physiol Endocrinol Metab
15941785
|
1 |
4.142 |
2005 |
|
Effects of bovine somatotropin on beta-casein mRNA levels in mammary tissue of lactating cows.
|
J Dairy Sci
16027194
|
5 |
2.474 |
2005 |
|
Parenteral nutrition in advanced cancer: indications and clinical practice guidelines.
|
J Palliat Med
16238503
|
0 |
2.23 |
2005 |
|
Regulation of protein catabolism by muscle-specific and cytokine-inducible ubiquitin ligase E3alpha-II during cancer cachexia.
|
Cancer Res
15548684
|
31 |
9.122 |
2004 |
|
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.
|
FASEB J
14718385
|
630 |
5.498 |
2004 |
|
n-3 Polyunsaturated fatty acids throughout the cancer trajectory: influence on disease incidence, progression, response to therapy and cancer-associated cachexia.
|
Nutr Res Rev
19079925
|
13 |
4.844 |
2004 |
|
Animal models of amino acid metabolism: a focus on the intestine.
|
J Nutr
15173447
|
6 |
4.145 |
2004 |
|
Skeletal muscle protein mobilization during the progression of lactation.
|
Am J Physiol Endocrinol Metab
15507537
|
7 |
4.142 |
2004 |
|
USP19 is a ubiquitin-specific protease regulated in rat skeletal muscle during catabolic states.
|
Am J Physiol Endocrinol Metab
15562254
|
40 |
4.142 |
2004 |
|
Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study.
|
J Clin Oncol
12506181
|
43 |
24.008 |
2003 |
|
Understanding and managing cancer cachexia.
|
J Am Coll Surg
12831935
|
40 |
4.307 |
2003 |
|
Modulation of intestinal protein synthesis and protease mRNA by luminal and systemic nutrients.
|
Am J Physiol Gastrointest Liver Physiol
12571084
|
5 |
3.468 |
2003 |
|
Parturition body size and body protein loss during lactation influence performance during lactation and ovarian function at weaning in first-parity sows.
|
J Anim Sci
12817500
|
16 |
1.863 |
2003 |
|
Selective protein loss in lactating sows is associated with reduced litter growth and ovarian function.
|
J Anim Sci
12661656
|
17 |
1.863 |
2003 |
|
Expression and activity of matrix metallo proteinases 2 and 9 and their inhibitors in rat lungs during the perinatal period and in diaphragmatic hernia.
|
Exp Lung Res
12746050
|
2 |
1.069 |
2003 |
|
Overview on metabolic adaptation to stress.
|
Nestle Nutr Workshop Ser Clin Perform Programme
12968445
|
1 |
0 |
2003 |
|
Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation.
|
Br J Cancer
12454764
|
19 |
6.176 |
2002 |
|
Increased muscle proteolysis after local trauma mainly reflects macrophage-associated lysosomal proteolysis.
|
Am J Physiol Endocrinol Metab
11788364
|
12 |
4.142 |
2002 |
|
Hypercatabolism and hypermetabolism in wasting states.
|
Curr Opin Clin Nutr Metab Care
11953647
|
11 |
4.023 |
2002 |
|
Elevated rate of collagen solubilization and postmortem degradation in muscles of lambs with high growth rates: possible relationship with activity of matrix metalloproteinases.
|
J Anim Sci
12162654
|
2 |
1.863 |
2002 |
|
Management of muscle wasting in cancer-associated cachexia: understanding gained from experimental studies.
|
Cancer
11598885
|
18 |
6.072 |
2001 |
|
A deadly combination of anorexia and hypermetabolism.
|
Curr Opin Clin Nutr Metab Care
11517348
|
0 |
4.023 |
2001 |
|
Coordinate expression of matrix-degrading proteinases and their activators and inhibitors in bovine skeletal muscle.
|
J Anim Sci
11204721
|
9 |
1.863 |
2001 |
|
Nutrition and athletic performance.
|
Can J Appl Physiol
11897877
|
0 |
0 |
2001 |
|
Cytokines and endotoxin induce cytokine receptors in skeletal muscle.
|
Am J Physiol Endocrinol Metab
10893340
|
13 |
4.142 |
2000 |
|
A panoply of anabolic and catabolic mediators.
|
Curr Opin Clin Nutr Metab Care
10871230
|
1 |
4.023 |
2000 |
|
Anabolic and catabolic mediators of intestinal protein turnover: a new experimental approach.
|
Curr Opin Clin Nutr Metab Care
10871233
|
0 |
4.023 |
2000 |
|
The activity of transcription factor Stat5 responds to prolactin, growth hormone, and IGF-I in rat and bovine mammary explant culture.
|
J Anim Sci
11132826
|
13 |
1.863 |
2000 |
|
Physiological levels of Stat5 DNA binding activity and protein in bovine mammary gland.
|
J Anim Sci
11132827
|
9 |
1.863 |
2000 |
|
Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia.
|
Nutrition
11054610
|
36 |
1.325 |
2000 |
|
Animal models for nutrition in cancer.
|
Nestle Nutr Workshop Ser Clin Perform Programme
11490572
|
2 |
0 |
2000 |
|
Amino acid nutrition and immune function in tumour-bearing rats: a comparison of glutamine-, arginine- and ornithine 2-oxoglutarate-supplemented diets.
|
Clin Sci (Lond)
10585893
|
4 |
4.936 |
1999 |
|
Luminal amino acids acutely decrease intestinal mucosal protein synthesis and protease mRNA in piglets.
|
J Nutr
10498761
|
2 |
4.145 |
1999 |
|
Anabolic and catabolic mediators.
|
Curr Opin Clin Nutr Metab Care
10498450
|
1 |
4.023 |
1999 |
|
Jejunal mucosal protein synthesis: validation of luminal flooding dose method and effect of luminal osmolarity.
|
Am J Physiol
9886973
|
1 |
0 |
1999 |
|
Anabolic and catabolic mediators.
|
Curr Opin Clin Nutr Metab Care
10565355
|
1 |
4.023 |
1998 |
|
Feeding lactating primiparous sows to establish three divergent metabolic states: II. Effect on nitrogen partitioning and skeletal muscle composition.
|
J Anim Sci
9581940
|
7 |
1.863 |
1998 |
|
Dietary L-glutamine supplementation reduces the growth of the Morris Hepatoma 7777 in exercise-trained and sedentary rats.
|
J Nutr
9040560
|
10 |
4.145 |
1997 |
|
Dietary L-glutamine does not improve lymphocyte metabolism or function in exercise-trained rats.
|
Med Sci Sports Exerc
9107629
|
3 |
4.141 |
1997 |
|
Reduced splenocyte metabolism and immune function in rats implanted with the Morris Hepatoma 7777.
|
Metabolism
8692020
|
0 |
5.777 |
1996 |
|
Effects of ranolazine on oxidative substrate preference in epitrochlearis muscle.
|
J Appl Physiol (1985)
8872662
|
7 |
3.351 |
1996 |
|
Dietary fat modifies exercise-dependent glucose transport in skeletal muscle.
|
J Appl Physiol (1985)
8926249
|
4 |
3.351 |
1996 |
|
Protein metabolism in cachectic tumor-bearing rats: effect of tumor excision.
|
J Surg Res
8592416
|
1 |
2.187 |
1996 |
|
Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats.
|
Metabolism
7476295
|
24 |
5.777 |
1995 |
|
Tissue protein turnover is altered during catch-up growth following Escherichia coli infection in weanling rats.
|
J Nutr
7876927
|
7 |
4.145 |
1995 |
|
Activation of the ATP-ubiquitin-proteasome pathway in skeletal muscle of cachectic rats bearing a hepatoma.
|
Am J Physiol
7539218
|
95 |
0 |
1995 |
|
Insulin-like growth factor-1 and insulin resistance in skeletal muscles of adult and old rats.
|
Endocrinology
8119189
|
19 |
4.286 |
1994 |
|
Dietary omega-3 and polyunsaturated fatty acids modify fatty acyl composition and insulin binding in skeletal-muscle sarcolemma.
|
Biochem J
8192673
|
25 |
3.797 |
1994 |
|
Dietary lipids influence insulin action.
|
Ann N Y Acad Sci
8352437
|
12 |
4.706 |
1993 |
|
The effect of a cold environment on protein and energy metabolism in calves.
|
Br J Nutr
8457522
|
3 |
3.706 |
1993 |
|
Catch-up growth following Escherichia coli infection in weanling rats.
|
Metabolism
1736044
|
0 |
5.777 |
1992 |
|
Dietary omega 3 fatty acid alters prostaglandin synthesis, glucose transport and protein turnover in skeletal muscle of healthy and diabetic rats.
|
Biochem J
1530573
|
9 |
3.797 |
1992 |
|
Northern and in situ hybridization analyses of the effects of somatotropin on bovine mammary gene expression.
|
J Dairy Sci
1430476
|
3 |
2.474 |
1992 |
|
Glutamine metabolism in skeletal muscles from the broiler chick (Gallus domesticus) and the laboratory rat (Rattus norvegicus)
|
Biochem J
2012604
|
7 |
3.797 |
1991 |
|
Tissue protein synthesis in lactating and dry goats.
|
Br J Nutr
1772870
|
5 |
3.706 |
1991 |
|
Prostaglandin synthesis and fatty acid composition of phospholipids and triglycerides in skeletal muscle of chicks fed combinations of flaxseed oil and animal tallow.
|
Lipids
1762521
|
2 |
1.934 |
1991 |
|
Influence of dietary flaxseed oil on the performance, muscle protein deposition, and fatty acid composition of broiler chicks.
|
Poult Sci
1886847
|
5 |
1.908 |
1991 |
|
Effect of systemic inhibition of prostaglandin synthesis on muscle protein balance after trauma in the rat.
|
Can J Physiol Pharmacol
1913329
|
3 |
1.822 |
1991 |
|
Molecular evidence for the presence of growth hormone receptors in the bovine mammary gland.
|
J Endocrinol
2212926
|
5 |
4.706 |
1990 |
|
Ultrastructural events following acute muscle trauma.
|
Med Sci Sports Exerc
2355815
|
18 |
4.141 |
1990 |
|
Influence of dietary carbohydrate-to-fat ratio on whole body nitrogen retention and body composition in adult rats.
|
J Nutr
2795238
|
2 |
4.145 |
1989 |
|
Prostaglandin-dependent muscle wasting during infection in the broiler chick (Gallus domesticus) and the laboratory rat (Rattus norvegicus).
|
Biochem J
2688631
|
6 |
3.797 |
1989 |
|
Exercise inhibits progressive growth of the Morris hepatoma 7777 in male and female rats.
|
Can J Physiol Pharmacol
2598121
|
9 |
1.822 |
1989 |
|
Effects of systemic inhibition of prostaglandin production on protein metabolism in tumor-bearing rats.
|
Am J Physiol
2764090
|
19 |
0 |
1989 |
|
Effect of Escherichia coli infection on growth and protein metabolism in broiler chicks (Gallus domesticus).
|
Comp Biochem Physiol A Comp Physiol
2573477
|
2 |
0 |
1989 |
|
An in vitro preparation of the extensor digitorum communis muscle from the chick (Gallus domesticus) for studies of protein turnover.
|
Comp Biochem Physiol A Comp Physiol
2566420
|
5 |
0 |
1989 |
|
Effect of bovine somatotropin on the distribution of immunoreactive insulin-like growth factor-I in lactating bovine mammary tissue.
|
J Dairy Sci
3068266
|
1 |
2.474 |
1988 |
|
Role of factors derived from activated macrophages in regulation of muscle protein turnover.
|
Adv Exp Med Biol
3266706
|
0 |
1.937 |
1988 |
|
The metabolic cost of fever.
|
Can J Physiol Pharmacol
3621073
|
20 |
1.822 |
1987 |
|
Maintenance of normal length improves protein balance and energy status in isolated rat skeletal muscles.
|
Am J Physiol
3464216
|
13 |
0 |
1986 |
|
Ca2+, interleukin-1 and failure to maintain normal length stimulate protein degradation in isolated skeletal muscle.
|
Prog Clin Biol Res
3875865
|
0 |
0 |
1985 |
|
Effects of temperature on protein turnover in isolated rat skeletal muscle.
|
Am J Physiol
6696054
|
7 |
0 |
1984 |
|
Adherence to combined exercise and dietary intervention in patients with gastrointestinal cancer undergoing neo-adjuvant therapy: an open-label, pilot, randomized controlled trial.
|
Research Square (Research Square)
W4283374556
|
0 |
0.01 |
2022 |
